Download PDF
Z Gastroenterol 2012; 50(02): 232-233
DOI: 10.1055/s-0031-1281994
Kommentiertes Referat
© Georg Thieme Verlag KG Stuttgart · New York

Risikoreduktion des hepatozellulären Karzinoms bei Patienten mit Leberzirrhose und Diabetes mellitus durch Metformin – Zeit für einen Paradigmenwechsel?

Risk Reduction of Hepatocellular Carcinoma by Metformin – Time for a Change of Paradigm?
F. Gundling
,
W. Schepp
Further Information

Publication History

Publication Date:
01 February 2012 (online)

Also available at
    Permissions and Reprints

Nkontchou G, Cosson E, Aout M, Mahmoudi A, Bourcier V, Charif I, Ganne-Carrie N, Grando-Lemaire V, Vicaut E, Trinchet JC, Beaugrand M. Impact of metformin on the prognosis of cirrhosis induced by viral hepatitis C in diabetic patients. J Clin Endocrinol Metab 2011; 96: 2601 – 2608